J&J's ketamine-derived nasal spray approved by FDA to treat depression
Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those ...
NJBIZ11h
J&J’s ketamine-based drug approved as standalone treatment
"Treatment-resistant depression can be very complicated, especially for patients who do not respond to oral antidepressants ...
KFDI18h
JJ’s Country Music Minute: Shay Mooney and His Wife Celebrate, Carrie Complains, Bailey Apologizes and More
Share on Facebook Share on Twitter Jason Aldean is hitting the road in 2025. He just announced his Full Throttle Tour. Jason ...
FDA approves standalone use of J&J's ketamine-derived depression treatment
The U.S. Food and Drug Administration expanded approval for Johnson & Johnson's nasal spray, Spravato, to allow it to be used ...
pharmaphorum18h
J&J's Spravato gets another lift with new FDA approval
The accelerating sales growth of Johnson & Johnson's Spravato could go up yet another gear after the FDA approved a third ...
GlobalData on MSN16h
J&J’s Spravato receives FDA label expansion for depression monotherapy
The FDA’s decision marks J&J's Spravato as the first monotherapy for adults with treatment-resistant depression.
Tractor-trailer truck rolls over with children inside, leads to fuel spill in Farmington
FARMINGTON, (WGME) -- The Farmington Police Department says a tractor-trailer truck went off the road in Farmington on Sunday ...
FDA approves J&J’s nasal spray for severe depression as stand-alone treatment
Johnson & Johnson's Spravato nasal spray has been FDA-approved as a stand-alone therapy for adults with treatment-resistant ...